Skip to main content
SpringerLink
Log in

Pharmacological Approaches to the Regression of Atherosclerotic Lesions of the Carotid or Coronary Arteries

  • Conference paper
Heart-Brain Interactions

  • 65 Accesses

Abstract

The clinical importance of atherosclerotic manifestations in the carotid and/or coronary arteries with regard to both morbidity and mortality has stimulated investigations about the beneficial effects of various therapeutic approaches aiming at a retardation or even at a regression of the disease. To date one can discuss the results of several well-controlled trials in both basic science and the clinical field. Nevertheless, some important questions remain to be solved in the future. This overview addresses possible pharmacological approaches to the retardation or regression of atherosclerosis. In the literature, one encounters mainly intervention studies with drugs in patients with coronary artery disease (CAD). Thus, it remains somewhat speculative whether these results can pertain to carotid artery lesions too.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brooks SH, Blankenborn DH, Chin HP, Sanmarco ME, Hanashiro PK, Selzer RH, Selvester RH (1980) Design of human atherosclerosis studies by serial angiography. J Chronic Dis 33: 347–357

    Article  CAS  PubMed  Google Scholar 

  2. Brown BG, Bolson EL, Dodge HT (1982) Artériographie evaluation of coronary atherosclerosis. Arteriosclerosis 2: 2–15

    Article  CAS  PubMed  Google Scholar 

  3. Crawford DW, Brooks SH, Selzer RH, Barndt R Jr, Beckenbach Es, Blankenborn DH (1977) Computer densitometry for angiographic assessment of arterial cholesterol content and gross pathology in human atherosclerosis. J Lab Clin Med 89: 378–392

    CAS  PubMed  Google Scholar 

  4. Detre KM, Wright E, Murphy ML, Takaro T (1975) Observer agreement in evaluating coronary angiograms. Circulation 52: 979–986

    Article  CAS  PubMed  Google Scholar 

  5. Jost S, Deckers J, Nellessen U, Rafflenbeul W, Hecker H, Reiber JCH, Lippolt P, Hugenholtz PG, Lichtlen PR, INTACT-Studiengruppe (1989) Computergestützte geometrische Meßtechnik in koronarangiographischen Intervallstudien: Ergebnisse bei Erstangiogrammen der INTACT- Studie. Z Kardiol 78: 23–32

    CAS  PubMed  Google Scholar 

  6. Reiber JHC, Serruys PW, Kooijman CJ, Wijns W, Slager CJ, Gerbrands JJ, Schuurbiers JHC, den Boer A, Hugenholtz PG (1985) Assessment of short-, medium- and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 71: 280–288

    Article  CAS  PubMed  Google Scholar 

  7. Bollinger A (1987) Apparative Möglichkeiten zur Langzeitbeobachtung. Vasa 20 [Suppl]: 88–89

    Google Scholar 

  8. Bond MG, Strickland HL, Wilmoth SK, Safrit A, Phillips R, Szostak L (1999) Interventional clinical trials using noninvasive ultrasound end points: the multicenter isradipine/diuretic atherosclerosis study. J Cardiovasc Pharmacdl 15 [Suppl]: S30–S33

    Article  Google Scholar 

  9. Chambers BR, Norris JW (1986) Outcome in patients with asymptomatic neck bruits. N Engl J Med 315: 860

    Article  CAS  PubMed  Google Scholar 

  10. Ehringer H, Bockelmann L, Konecny U, Koppensteiner R, Marosi L, Minar E, Schöfl R (1987) Verschlußkrankheit der extrakraniellen A. carotis: “Spontanverlauf” und frühe Phase nach Thrombendarteriektomie im bildgebenden Ultraschall. Vasa 20 [Suppl]: 71–76

    CAS  PubMed  Google Scholar 

  11. Hennerici M, Rautenberg W, Trockel U, Kladetzky RG (1985) Spontaneous progression and regression of small carotid atheroma. Lancet i: 1415–1419

    Google Scholar 

  12. Hennerici M, Steinke W (1987) Morphologie und biochemische Parameter zur Regression von Karotisläsionen. Vasa 20 [Suppl]: 77–84

    CAS  PubMed  Google Scholar 

  13. Javid H, Ostermiller WE Jr, Hemgesh JW, Dye WS, Hunter JA, Najafi H, Julian OC (1970) Natural history of carotid bifurcation atheroma. Surgery 67: 80

    CAS  PubMed  Google Scholar 

  14. Roederer GO, Langlois Y, Jäger KA, Primozich JF, Beach KW, Phillips DJ, Strandness DE Jr (1984) The natural history of carotid arterial disease in asymptomatic patients with cervical bruits. Stroke 15: 605–609

    Article  CAS  PubMed  Google Scholar 

  15. Bond MG, Adams MR, Bullock BC (1981) Complicating factors in evaluating coronary atherosclerosis. Artery 9: 21–29

    CAS  PubMed  Google Scholar 

  16. Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cahen-Hemphill L (1987) Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 257: 3233–3240

    Article  CAS  PubMed  Google Scholar 

  17. Borhani NO, Brugger SB, Byington RP (1990) Multicenter study with isradipine and diuretics against atherosclerosis. J Cardiovasc Pharmacol 15 [Suppl]: S23–S29

    Article  PubMed  Google Scholar 

  18. Bruschke AVG, Wijers TS, Kolsters W, Landmann J (1981) The anatomic evolution of coronary artery disease demonstrated by coronary arteriography in 256 nonoperated patients. Circulation 63: 527–536

    Article  CAS  PubMed  Google Scholar 

  19. Frick MH, Valle M, Harjola PT (1983) Progression of coronary artery disease: a prospective angiographic study of medical and surgical patients. In: Roskamm H (ed) Prognosis of coronary artery disease - progression of coronary arteriosclerosis. Springer, Berlin Heidelberg New York, p 177

    Chapter  Google Scholar 

  20. Breddin K, Loew D, Lechner K, Oberla K, Walter E (1980) The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. Circulation 62 [Suppl V]: 63–72

    Google Scholar 

  21. The Steering Committee of the Physicians’ Health Study Research Group (1988) Preliminary report: findings from the aspirin component of the ongoing Physicians’ Health Study. N Engl J Med 318: 262–264

    Article  Google Scholar 

  22. Schoop (1987) Progression und Regression der peripheren arteriellen VerschluBkrankheit; Spontanverlauf - ASS - ASS + Dipyridamol. Vasa 20 [Suppl]: 62–63

    Google Scholar 

  23. Duffield RGM, Lewis B, Miller NE, Jamieson CW, Brunt JNH, Colchester ACF (1983) Treatment of hyperlipemia retards progression of symptomatic femoral atherosclerosis. Lancet ii: 639–642

    Google Scholar 

  24. Brensike JF, Levy RI, Kelsey SF, Passamani ER, Richardson JM, Loh IK, Stone NJ, Aldrich RF, Battlaglini JW, Moriarty DJ, Fisher MR, Friedman L, Friedewald W, Detre KM, Epstein SE (1984) Effects of therapy with cholestyramine on progression of coronary atherosclerosis: results of the NHLBI type II coronary intervention study. Circulation 69: 313–324

    Article  CAS  PubMed  Google Scholar 

  25. Levy RI, Brensike JF, Epstein SE, Kelsey SF, Passamani ER, Richardson JM, Loh IK, Stone NJ, Aldrich RF, Battaglini JW, Moriarty DJ, Fisher ML, Friedman L, Friedewald W, Detre KM (1984) The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of the NHLBI type II coronary intervention study. Circulation 69: 325–337

    Article  CAS  PubMed  Google Scholar 

  26. Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan C, Zao XQ, Bisson BD, Fitzpatrick VF, Dodge HT (1990) Regression of coronary artery disease as a result of intensive lipid lowering therapy in men with high levels of apolipoprotein B. N pngl J Med 323: 1289–1298

    Article  CAS  Google Scholar 

  27. Betz E, Hammerle H, Kling D, Lenke D, Muller CD (1986) Wirkungen von Verapamil am Arteriosklerose-Modell. In: Rosenthal J (ed) Calcium-Antagonisten und Hypertonic - Aktueller Stand. Excerpta Medica, Amsterdam, pp 83–97

    Google Scholar 

  28. Etingin OR, Hajjar DP (1985) Nifedipine increases cholesteryl ester hydrolytic activity in lipid- laden rabbit arterial smooth muscle cells: a possible mechanism for its antiaatherogenic effect. J. Clin Invest 75: 1554–1558

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Henry PD, Bentley KL (1981) Suppression of atherogenesis in cholesterol-fed rabbits treated with nifedipine. J Clin Invest 68: 1366–1369

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Hugenholtz PG, Lichtlen P, Van der Giessen W, Becker AE, Nayler WG, Fleckenstein A, Hiilsmann WC (1986) On a possible role for calcium antagonists in atherosclerosis. A personal view. Eur Heart J 7: 546–559

    Google Scholar 

  31. Nayler WG (1988) Calcium antagonists and atherosclerosis. In: Nayler WG (ed) Calcium antagonists. Academic Harcourt Brace Jovanovich, London, pp 325–347

    Google Scholar 

  32. Stein O, Leitersdorf E, Stein Y (1985) Verapamil enhances receptor-mediated endocytosis of low-density lipoproteins by aortic cells in culture. Arteriosclerosis 5: 35–44

    Article  CAS  PubMed  Google Scholar 

  33. Lichtlen PR, Nellessen U, Rafflenbeul W, Jost S, Hecker H (1987) International Nifedipine Trial on Antiatherosclerotic therapy ( INTACT ). Cardiovasc Drugs Ther 1: 71–79

    Article  Google Scholar 

  34. Waters D, Freedman D, Lesperance J, Theroux P, Lemarbre L, Kamm B, Joyal M, Dyrda I, Gosselin G, Hudon G, Hache M, Halloran J, Havel RJ (1987) Design features of a controlled clinical trial to assess the effect of a calcium entry blocker upon the progression of coronary artery disease. Controlled Clin Trials 8: 216–242

    Article  CAS  PubMed  Google Scholar 

  35. Schneider W, Kober G, Roebruck P, Noack H, Aile M, Cieslinski G, Reifart N, Kaltenbach M (1990) Retardation of development and progression of coronary atherosclerosis: a new indication for calcium antagonists? Eûr J Clin Pharmacol 39 [Suppl 1]: S17–S23

    Article  CAS  PubMed  Google Scholar 

  36. Lichtlen PR, Hugenholtz PG, Raffienbeul W, Hecker H, Jost S, Deckers JW (1990) Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Trial on Antiatherosclerotic Therapy ( INTACT ). Lancet 335: 1109–1113

    Article  CAS  PubMed  Google Scholar 

  37. Waters D, Lespérance J, Francetich M, Causey D, Théroux P, Chiang Y, Hudon J, Lemarbre L, Reitmann M, Joyal M, Gosselin G, Dyrda I, Macer J, and Havel RJ (1990) A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. Circulation 82: 1940–1953

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Cardiology, Johann Wolfgang Goethe University, Frankfurt am Main, Germany

    W. Schneider

Authors
  1. W. Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Cardiology, Bellaria Hospital, Bologna, Italy

    Giuseppe Di Pasquale M.D.  & Giuseppe Pinelli M.D.  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schneider, W. (1992). Pharmacological Approaches to the Regression of Atherosclerotic Lesions of the Carotid or Coronary Arteries. In: Di Pasquale, G., Pinelli, G. (eds) Heart-Brain Interactions. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76652-7_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76652-7_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-76654-1

  • Online ISBN: 978-3-642-76652-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation